In the News
Stay up to date on the latest news, announcements, and perspectives from Thyme Companies. See how our companies are working together to build a more connected cancer care system — bringing care delivery, treatment access, and payment together around the people we serve.
Press Release
Thyme Companies Launches First New Venture, Thyme Therapeutics, To Build a More Sustainable, Lower-Cost Oncology Biosimilar Model
Thyme Companies announced the launch of Thyme Therapeutics, a new business focused on driving reductions in the cost of oncology drugs.
Press Release
Thyme Companies Names Carolyn Starrett, Former Flatiron Health CEO, as Executive Vice President, New Ventures
Carolyn Starrett has joined as executive vice president of new ventures, with more than two decades of experience across oncology, clinical research, biopharma, and data.
Press Release
Thyme Care Closes $125+ Million Series E, Establishes Thyme Companies to Broaden Its Impact Across the Oncology Ecosystem
The new capital fuels Thyme Care's growth and establishes Thyme Companies, a parent entity building a portfolio of businesses.
Media: CNBC Disrupter 50
Thyme Care raises $125 million, pushing cancer care startup’s valuation above $2 billion
Thyme Care closes gaps in cancer care through virtual navigation. It is now forming a parent company to build businesses tackling challenges from drug affordability to clinical trial access.